Scalper1 News
The highly rated generic-drugs industry group boasts a number of stocks that are either in buying range or working on bases. Actavis (ACT) is trying to break out past the 216.80 buy point of a cup-with-handle base. The base is third stage, which makes it riskier than those that form earlier in a stock’s run-up. Medical stocks have enjoyed a long uptrend amid strong earnings growth and a rush of M&A activity, which has been spurred by growing Scalper1 News
Scalper1 News